|
1
|
Haapaniemi A, Koivunen P, Saarilahti K,
Kinnunen I, Laranne J, Aaltonen LM, Närkiö M, Lindholm P, Grénman
R, Mäkitie A, et al: Laryngeal cancer in Finland: A 5-year
follow-up study of 366 patients. Head Neck. 38:36–43. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steuer CE, El-Deiry M, Parks JR, Higgins
KA and Saba NF: An update on larynx cancer. CA Cancer J Clin.
67:31–50. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gong H, Shi Y, Xiao X, Cao P, Wu C, Tao L,
Hou D, Wang Y and Zhou L: Alterations of microbiota structure in
the larynx relevant to laryngeal carcinoma. Sci Rep. 7:55072017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rudolph E, Dyckhoff G, Becher H, Dietz A
and Ramroth H: Effects of tumour stage, comorbidity and therapy on
survival of laryngeal cancer patients: A systematic review and a
meta-analysis. Eur Arch Otorhinolaryngol. 268:165–179. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bach LA: IGF-binding proteins. J Mol
Endocrinol. 61:T11–T28. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jal L, Ram M, Akl R, van der Zee AGJ and
de Jong S: IGF system targeted therapy: Therapeutic opportunities
for ovarian cancer. Cancer Treat Rev. 60:90–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Winder T, Zhang W, Yang D, Ning Y, Bohanes
P, Gerger A, Wilson PM, Pohl A, Mauro DJ, Langer C, et al: Germline
polymorphisms in genes involved in the IGF1 pathway predict
efficacy of cetuximab in wild-type KRAS mCRC patients. Clin Cancer
Res. 16:5591–5602. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mountzios G, Kostopoulos I, Kotoula V,
Sfakianaki I, Fountzilas E, Markou K, Karasmanis I, Leva S,
Angouridakis N, Vlachtsis K, et al: Insulin-like growth factor 1
receptor (IGF1R) expression and survival in operable squamous-cell
laryngeal cancer. PLoS One. 8:e540482013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun J, Li W, Sun Y, Yu D, Wen X, Wang H,
Cui J, Wang G, Hoffman AR and Hu JF: A novel antisense long
noncoding RNA within the IGF1R gene locus is imprinted in
hematopoietic malignancies. Nucleic Acids Res. 42:9588–9601. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kang L, Sun J, Wen X, Cui J, Wang G,
Hoffman AR, Hu JF and Li W: Aberrant allele-switch imprinting of a
novel IGF1R intragenic antisense non-coding RNA in breast cancers.
Eur J Cancer. 51:260–270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng J, Sun Y, Zhang EB, Lu XY, Jin SD and
Guo RH: A novel long noncoding RNA IRAIN regulates cell
proliferation in non small cell lung cancer. Int J Clin Exp Pathol.
8:12268–12275. 2015.PubMed/NCBI
|
|
12
|
Pashaiefar H, Izadifard M, Yaghmaie M,
Montazeri M, Gheisari E, Ahmadvand M, Momeny M, Ghaffari SH,
Kasaeian A, Alimoghaddam K and Ghavamzadeh A: Low expression of
long noncoding RNA IRAIN is associated with poor prognosis in
Non-M3 acute myeloid leukemia patients. Genet Test Mol Biomarkers.
22:288–294. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo J, Wu J, Li Z, Qin H, Wang B, Wong TS,
Yang W, Fu QL and Lei W: miR-375 suppresses IGF1R expression and
contributes to inhibition of cell progression in laryngeal squamous
cell carcinoma. Biomed Res Int. 2014:3745982014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
National Comprehensive Cancer Network
(NCCN), . NCCN Clinical Practice Guidelines in Oncology-Head and
Neck Cancers. Version 1.2018. NCCN, Plymouth Meeting. (PA).
2018.
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kwok CT and Hitchins MP: Allele
quantification Pyrosequencing® at designated SNP sites
to detect allelic expression imbalance and Loss-of-Heterozygosity.
Methods Mol Biol. 1315:153–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang ZM, Wang DZ and Shi JX: Detection and
application of allelic expression imbalance. Zhonghua Yu Fang Yi
Xue Za Zhi. 45:9–11. 2011.(In Chinese). PubMed/NCBI
|
|
18
|
Sun M and Kraus WL: From discovery to
function: The expanding roles of long noncoding RNAs in physiology
and disease. Endocr Rev. 36:25–64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Grelet S, Link LA, Howley B, Obellianne C,
Palanisamy V, Gangaraju VK, Diehl JA and Howe PH: A regulated PNUTS
mRNA to lncRNA splice switch mediates EMT and tumour progression.
Nat Cell Biol. 19:1105–1115. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J,
Wei M, Xu C, Wu C, Zhang Z, et al: Long non-coding RNA metastasis
associated in lung adenocarcinoma transcript 1 derived miniRNA as a
novel plasma-based biomarker for diagnosing prostate cancer. Eur J
Cancer. 49:2949–2959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Collette J, Le Bourhis X and Adriaenssens
E: Regulation of human breast cancer by the long Non-coding RNA
H19. Int J Mol Sci. 18:23192017. View Article : Google Scholar
|
|
22
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Conigliaro A, Costa V, Lo Dico A, Saieva
L, Buccheri S, Dieli F, Manno M, Raccosta S, Mancone C, Tripodi M,
et al: CD90+ liver cancer cells modulate endothelial cell phenotype
through the release of exosomes containing H19 lncRNA. Mol Cancer.
14:1552015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lv M, Zhong Z, Huang M, Tian Q, Jiang R
and Chen J: lncRNA H19 regulates epithelial-mesenchymal transition
and metastasis of bladder cancer by miR-29b-3p as competing
endogenous RNA. Biochim Biophys Acta Mol Cell Res. 1864:1887–1899.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu T, Qu L, He G, Tian L, Li L, Zhou H,
Jin Q, Ren J, Wang Y, Wang J, et al: Regulation of laryngeal
squamous cell cancer progression by the lncRNA
H19/miR-148a-3p/DNMT1 axis. Oncotarget. 7:11553–11566. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y and Hu H: Long non-coding RNA
CCAT1/miR-218/ZFX axis modulates the progression of laryngeal
squamous cell cancer. Tumour Biol.
39:10104283176994172017.PubMed/NCBI
|
|
27
|
Zhang Z, Wang X, Cao S, Han X, Wang Z,
Zhao X, Liu X, Li G, Pan X and Lei D: The long noncoding RNA TUG1
promotes laryngeal cancer proliferation and migration. Cell Physiol
Biochem. 49:2511–2520. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang P, Wu T, Zhou H, Jin Q, He G, Yu H,
Xuan L, Wang X, Tian L, Sun Y, et al: Long noncoding RNA NEAT1
promotes laryngeal squamous cell cancer through regulating
miR-107/CDK6 pathway. J Exp Clin Cancer Res. 35:222016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fountzilas E, Kotoula V, Angouridakis N,
Karasmanis I, Wirtz RM, Eleftheraki AG, Veltrup E, Markou K,
Nikolaou A, Pectasides D and Fountzilas G: Identification and
validation of a multigene predictor of recurrence in primary
laryngeal cancer. PLoS One. 8:e704292013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Z, Liu Q, Tieqiang L, Xiaodong L,
Guangwei Z, Yang L, Hao Z and Chaoyang Z: Abnormal expressed long
non-coding RNA IRAIN inhibits tumor progression in human renal cell
carcinoma cells. Open Life Sci. 11:200–205. 2016. View Article : Google Scholar
|
|
31
|
Lian Y, Wang J, Feng J, Ding J, Ma Z, Li
J, Peng P, De W and Wang K: Long non-coding RNA IRAIN suppresses
apoptosis and promotes proliferation by binding to LSD1 and EZH2 in
pancreatic cancer. Tumour Biol. 37:14929–14937. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu JF, Balaguru KA, Ivaturi RD, Oruganti
H, Li T, Nguyen BT, Vu TH and Hoffman AR: Lack of reciprocal
genomic imprinting of sense and antisense RNA of mouse insulin-like
growth factor II receptor in the central nervous system. Biochem
Biophys Res Commun. 257:604–608. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu JF, Pham J, Dey I, Li T, Vu TH and
Hoffman AR: Allele-specific histone acetylation accompanies genomic
imprinting of the insulin-like growth factor II receptor gene.
Endocrinology. 141:4428–4435. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stöger R, Kubicka P, Liu CG, Kafri T,
Razin A, Cedar H and Barlow DP: Maternal-specific methylation of
the imprinted mouse Igf2r locus identifies the expressed locus as
carrying the imprinting signal. Cell. 73:61–71. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wutz A, Smrzka OW, Schweifer N,
Schellander K, Wagner EF and Barlow DP: Imprinted expression of the
Igf2r gene depends on an intronic CpG island. Nature. 389:745–749.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cabili MN, Trapnell C, Goff L, Koziol M,
Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human
large intergenic noncoding RNAs reveals global properties and
specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yan H, Yuan W, Velculescu VE, Vogelstein B
and Kinzler KW: Allelic variation in human gene expression.
Science. 297:11432002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Barlow DP and Bartolomei MS: Genomic
imprinting in mammals. Cold Spring Harb Perspect Biol.
6:a0183822014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li E and Zhang Y: DNA methylation in
mammals. Cold Spring Harb Perspect Biol. 6:a0191332014. View Article : Google Scholar : PubMed/NCBI
|
